Skye Bioscience
SKYE • NASDAQ
Skye Bioscience is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Punit S. Dhillon, with a market cap of $121.2M.
CEOPunit S. Dhillon
Next Earnings
Upcoming earnings announcement for Skye Bioscience
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.32
Earnings History
Past 7 earnings reports for Skye Bioscience
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.36Est: -$0.30 | -20.0% | - | — |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.32Est: -$0.32 | 0.0% | - | — | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.44Est: -$0.32 | -37.5% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.28Est: -$0.29 | +3.4% | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.24Est: -$0.28 | +14.3% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.10Est: -$0.25 | +60.0% | - | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$0.20 | — | - | — | 10-Q |